{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:08:38Z","timestamp":1776298118378,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009450","name":"Universidad Pontificia Bolivariana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009450","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["111565740967"],"award-info":[{"award-number":["111565740967"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.preghy.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T19:53:22Z","timestamp":1657137202000},"page":"92-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia"],"prefix":"10.1016","volume":"29","author":[{"given":"Catalina M.","family":"Valencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa R.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Burwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas A.","family":"Vel\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Guti\u00e9rrez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Edna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime L.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Trujillo-Ot\u00e1lvaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Vargas-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamile","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2022.07.001_b0005","unstructured":"American College of Obstetricians, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 2013;122(5):1122-1131."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.001_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal Mortality From Preeclampsia\/Eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin. Perinatol."},{"issue":"4","key":"10.1016\/j.preghy.2022.07.001_b0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.001_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9378(97)70438-1","article-title":"Placental apoptosis in normal human pregnancy","volume":"177","author":"Smith","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.preghy.2022.07.001_b0025","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/clinchem\/46.11.1832","article-title":"Presence of fetal RNA in maternal plasma","volume":"46","author":"Poon","year":"2000","journal-title":"Clin. Chem."},{"issue":"9076","key":"10.1016\/j.preghy.2022.07.001_b0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet (London, England)."},{"issue":"5","key":"10.1016\/j.preghy.2022.07.001_b0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia Is Characterized by Placental Complement Dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.preghy.2022.07.001_b0040","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b\u20139 in severe preeclampsia: tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2022.07.001_b0045","doi-asserted-by":"crossref","first-page":"S1059","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"226","author":"Burwick","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.001_b0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2022.07.001_b0055","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.preghy.2022.07.001_b0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b\u20139 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.preghy.2022.07.001_b0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal Complement Activation in Preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"23","key":"10.1016\/j.preghy.2022.07.001_b0070","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.preghy.2022.07.001_b0075","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2022.07.001_b0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.001_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82733-z","article-title":"Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics","volume":"11","author":"Youssef","year":"2021","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.preghy.2022.07.001_b0090","first-page":"31129","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"S0002\u20139378","author":"Burwick","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.preghy.2022.07.001_b0095","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.preghy.2022.07.001_b0100","doi-asserted-by":"crossref","first-page":"518.e1","DOI":"10.1016\/j.ajog.2020.11.004","article-title":"Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes","volume":"224","author":"Lai","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2022.07.001_b0105","doi-asserted-by":"crossref","first-page":"217.e1","DOI":"10.1016\/j.ajog.2020.08.019","article-title":"The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study","volume":"224","author":"Reddy","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2022.07.001_b0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.preghy.2019.11.011","article-title":"Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia","volume":"19","author":"Bouter","year":"2020","journal-title":"Pregnancy Hypertens."},{"issue":"2","key":"10.1016\/j.preghy.2022.07.001_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2022.07.001_b0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2020.00548","article-title":"Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report","volume":"11","author":"Lokki","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.preghy.2022.07.001_b0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/AOG.0000000000003570","article-title":"Pregnancy Prolongation After Eculizumab Use in Early-Onset Preeclampsia","volume":"134","author":"Lu","year":"2019","journal-title":"Obstet. Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892200068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892200068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:56:52Z","timestamp":1761897412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077892200068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"alternative-id":["S221077892200068X"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.07.001","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}]}}